From stem cells to extracellular vesicles: a new horizon in tissue engineering and regenerative medicine DOI
Gajanan K Arbade,

Jovel Varghese Jose,

Arvind Gulbake

и другие.

Cytotechnology, Год журнала: 2024, Номер 76(4), С. 363 - 401

Опубликована: Май 8, 2024

Язык: Английский

Spotlight on therapeutic efficiency of mesenchymal stem cells in viral infections with a focus on COVID-19 DOI Creative Commons
Saman Yasamineh, Hesam Ghafouri Kalajahi,

Pooneh Yasamineh

и другие.

Stem Cell Research & Therapy, Год журнала: 2022, Номер 13(1)

Опубликована: Июнь 17, 2022

Abstract The SARS-COV-2 virus has infected the world at a very high rate by causing COVID-19 disease. Nearly 507 million individuals have been with this virus, approximately 1.2% of these patients being dead, indicating that out control in many countries. While researchers are investigating how to develop efficient drugs and vaccines versus pandemic, new superseded treatments potential reduce mortality. recent application mesenchymal stem cells (MSCs) subgroup acute respiratory distress created benefits as supportive therapy for viral contagion conditions aged severe pneumonia. Consequently, within overview, we discuss role therapeutic MSCs challenges ahead using them treat infections, highlighting on infection. Graphical

Язык: Английский

Процитировано

37

Circulating microRNAs as emerging regulators of COVID-19 DOI Creative Commons
Yulong Liang, Dan Fang, Xiaojun Gao

и другие.

Theranostics, Год журнала: 2022, Номер 13(1), С. 125 - 147

Опубликована: Ноя. 29, 2022

Coronavirus disease 2019 , an infectious caused by the novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is a global pandemic that has high incidence rates, spreads rapidly, and more than 6.5 million deaths globally to date.Currently, several drugs have been used in clinical treatment of COVID-19, including antivirals (e.g., molnupiravir, baricitinib, remdesivir), monoclonal antibodies etesevimab tocilizumab), protease inhibitors paxlovid), glucocorticoids dexamethasone).Increasing evidence suggests circulating microRNAs (miRNAs) are important regulators viral infection antiviral immune responses, biological processes involved regulating COVID-19 subsequent complications.During infection, both genes host cytokines regulate transcriptional posttranscriptional steps affecting replication.Virus-encoded miRNAs component evasion repertoire function directly targeting functions.Moreover, can contribute escape play role not only promoting nonstructural protein (nsp) 10 expression SARS coronavirus, but among others inhibiting NOD-like receptor pyrin domain-containing (NLRP) 3 IL-1β transcription.Consequently, understanding mechanism action during SARS-CoV-2 will provide unexpected insights into miRNA-based studies.In this review, we examined recent progress regulation inflammatory response, dysfunction, thrombosis discussed mechanisms action, highlighted therapeutic challenges involving miRNA future research directions COVID-19.

Язык: Английский

Процитировано

31

Problems of Pathogenesis and Pathogenetic Therapy of COVID-19 from the Perspective of the General Theory of Pathological Systems (General Pathological Processes) DOI Open Access
Evgeni Gusev, Alexey Sarapultsev, Desheng Hu

и другие.

International Journal of Molecular Sciences, Год журнала: 2021, Номер 22(14), С. 7582 - 7582

Опубликована: Июль 15, 2021

The COVID-19 pandemic examines not only the state of actual health care but also fundamental medicine in various countries. Pro-inflammatory processes extend far beyond classical concepts inflammation. They manifest themselves a variety ways, beginning with extreme physiology, then allostasis at low-grade inflammation, and finally shockogenic phenomenon “inflammatory systemic microcirculation”. pathogenetic core critical situations, including COVID-19, is this phenomenon. Microcirculatory abnormalities, on other hand, lie heart specific type general pathological process known as inflammation (SI). Systemic inflammatory response, cytokine release, storm, thrombo-inflammatory syndrome are all terms that refer to different aspects SI. As result, metabolic model does adequately reflect pathophysiology persistent (ChSLGI). Diseases associated ChSLGI, risk factors for severe course. review role hypoxia, dysfunction, scavenger receptors, pattern-recognition well hemophagocytic syndrome, alteration development SI COVID-19.

Язык: Английский

Процитировано

36

Bio-Inspired Nanocarriers Derived from Stem Cells and Their Extracellular Vesicles for Targeted Drug Delivery DOI Creative Commons

Munire Abudurexiti,

Yue Zhao, Wang Xiao-ling

и другие.

Pharmaceutics, Год журнала: 2023, Номер 15(7), С. 2011 - 2011

Опубликована: Июль 24, 2023

With their seemingly limitless capacity for self-improvement, stem cells have a wide range of potential uses in the medical field. Stem-cell-secreted extracellular vesicles (EVs), as paracrine components cells, are natural nanoscale particles that transport variety biological molecules and facilitate cell-to-cell communication which been also widely used targeted drug delivery. These nanocarriers exhibit inherent advantages, such strong cell or tissue targeting low immunogenicity, synthetic lack. However, despite tremendous therapeutic EVs, further clinical application is still limited by yield lack standardized isolation purification protocols. In recent years, inspired concept biomimetics, new approach to biomimetic delivery has developed through combining nanotechnology bioengineering. This article reviews derived from EVs discusses advantages challenges order stimulate future research.

Язык: Английский

Процитировано

14

Regulatory role of miRNAs in the human immune and inflammatory response during the infection of SARS‐CoV‐2 and other respiratory viruses: A comprehensive review DOI
Chiranjib Chakraborty, Manojit Bhattacharya, Sang‐Soo Lee

и другие.

Reviews in Medical Virology, Год журнала: 2024, Номер 34(2)

Опубликована: Март 1, 2024

miRNAs are single-stranded ncRNAs that act as regulators of different human body processes. Several have been noted to control the immune and inflammatory response during severe acute respiratory infection syndrome (SARS-CoV-2) infection. Similarly, many were upregulated downregulated virus infections. Here, an attempt has made capture regulatory role in SARS-CoV-2 other viruses. Firstly, depicted SARS-CoV-2. In this direction, several significant points discussed about infection, such innate response; its regulation granulocytes; macrophage activation polarisation; neutrophil extracellular trap formation; miRNA-related association adaptive immunity. Secondly, landscape infections coronavirus, syncytial virus, influenza rhinovirus, metapneumovirus. The article will provide more understanding miRNA-controlled mechanism COVID-19, which help therapeutics discoveries fight against future pandemic.

Язык: Английский

Процитировано

5

Mesenchymal Stem Cell-Derived Exosome Therapy of Microbial Diseases: From Bench to Bed DOI Creative Commons

Xiaolan Wu,

Shanshan Jin,

Chengye Ding

и другие.

Frontiers in Microbiology, Год журнала: 2022, Номер 12

Опубликована: Янв. 3, 2022

Microbial diseases are a global health threat, leading to tremendous casualties and economic losses. The strategy treat microbial falls into two broad categories: pathogen-directed therapy (PDT) host-directed (HDT). As the typical PDT, antibiotics or antiviral drugs directly attack bacteria viruses through discerning specific molecules. However, drug abuse could result in antimicrobial resistance increase infectious disease morbidity. Recently, exosome therapy, as HDT, has attracted extensive attentions for its potential limiting complications targeted delivery. Mesenchymal stem cell-derived exosomes (MSC-Exos) most broadly investigated. In this review, we mainly focus on development recent advances of application MSC-Exos diseases. review starts with difficulties current strategies treatments, followed by comprehensive overview aspect isolation, identification, contents, applications. Then, underlying mechanisms MSC-Exo discussed depth, including immunomodulation, repression excessive inflammation, promotion tissue regeneration. addition, highlight latest progress clinical translation summarizing related trials, routes administration, modifications. This will provide fundamental insights future perspectives from bench bedside.

Язык: Английский

Процитировано

21

Mesenchymal Stem Cell-Derived Extracellular Vesicles in the Management of COVID19-Associated Lung Injury: A Review on Publications, Clinical Trials and Patent Landscape DOI Open Access
Anand Krishnan, Senthilkumar Muthusamy, Francis Fernandez

и другие.

Tissue Engineering and Regenerative Medicine, Год журнала: 2022, Номер 19(4), С. 659 - 673

Опубликована: Апрель 6, 2022

Язык: Английский

Процитировано

21

microRNAs and Inflammatory Immune Response in SARS-CoV-2 Infection: A Narrative Review DOI Creative Commons
Beatrice Maranini, Giovanni Ciancìo, Manuela Ferracin

и другие.

Life, Год журнала: 2022, Номер 12(2), С. 288 - 288

Опубликована: Фев. 15, 2022

The current SARS-CoV-2 pandemic has emerged as an international challenge with strong medical and socioeconomic impact. spectrum of clinical manifestations is wide, covering asymptomatic or mild cases up to severe life-threatening complications. Critical courses infection are thought be driven by the so-called “cytokine storm”, derived from excessive immune response that induces release proinflammatory cytokines chemokines. In recent years, non-coding RNAs (ncRNAs) potential diagnostic therapeutic biomarkers in both inflammatory infectious diseases. Therefore, identification miRNAs host important research topic, investigating host–virus crosstalk COVID-19 infection, trying answer pressing question whether miRNA-based therapeutics can employed tackle this review, we aimed directly address ncRNA role SARS-CoV-2-immune system upon particularly focusing on pathways cytokine storm syndromes.

Язык: Английский

Процитировано

20

miRNAs: The Key Regulator of COVID-19 Disease DOI Creative Commons
Leyla Tahrani Hardin, Nan Xiao

International Journal of Cell Biology, Год журнала: 2022, Номер 2022, С. 1 - 19

Опубликована: Окт. 29, 2022

As many parts of the world continue to fight innumerable waves COVID-19 infection, SARS-CoV-2 continues sculpt its antigenic determinants enhance virulence and evolvability. Several vaccines were developed used around world, oral antiviral medications are being against SARS-CoV-2. However, studies showed that virus is mutating in line with antibody's neutralization escape; thus, new therapeutic alternatives solicited. We hereby review key role miRNAs can play as epigenetic mediators cross-talk between host cells. The limitations resulting from "virus intelligence" escape antagonize well possible mechanisms could be viral evasion strategies discussed. Lastly, we suggest approaches based on miRNAs.

Язык: Английский

Процитировано

20

RETRACTED: Non-coding RNA in SARS-CoV-2: Progress toward therapeutic significance DOI Open Access

Hanieh Shirvani,

Hanieh Jafari,

Sayyed Sajjad Moravveji

и другие.

International Journal of Biological Macromolecules, Год журнала: 2022, Номер 222, С. 1538 - 1550

Опубликована: Сен. 22, 2022

Язык: Английский

Процитировано

19